These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9055048)

  • 21. The landmark surgical trials of the National Surgical Adjuvant Breast and Bowel Project.
    Wickerham DL; Costantino JP; Mamounas EP; Julian TB
    World J Surg; 2006 Jul; 30(7):1138-46. PubMed ID: 16794909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Difference in strategy for breast cancer between western countries and Japan].
    Saito M; Kasumi F
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):61-8. PubMed ID: 9987499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical management of de novo stage IV breast cancer.
    Patrick J; Khan SA
    J Natl Compr Canc Netw; 2015 Apr; 13(4):487-93; quiz 493. PubMed ID: 25870383
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The landscape and lexicon of blinding in randomized trials.
    Schulz KF; Chalmers I; Altman DG
    Ann Intern Med; 2002 Feb; 136(3):254-9. PubMed ID: 11827510
    [No Abstract]   [Full Text] [Related]  

  • 26. Overview of randomized trials of systemic adjuvant therapy.
    Ravdin P
    Cancer Treat Res; 2008; 141():55-62. PubMed ID: 18274082
    [No Abstract]   [Full Text] [Related]  

  • 27. Current controversies in breast cancer management.
    Morrow M; Jordan VC; Takei H; Gradishar WJ; Pierce LJ
    Curr Probl Surg; 1999 Mar; 36(3):163-216. PubMed ID: 10089889
    [No Abstract]   [Full Text] [Related]  

  • 28. More questions about the European Organisation for Research and Treatment of Cancer 22881-10882 boost trial.
    Guinot JL
    J Clin Oncol; 2011 Mar; 29(8):e212; author reply e213. PubMed ID: 21263085
    [No Abstract]   [Full Text] [Related]  

  • 29. [Adjuvant chemotherapy in breast and ovarian carcinoma].
    Kreienberg R
    Gynakologe; 1991 Aug; 24(4):208-14. PubMed ID: 1937162
    [No Abstract]   [Full Text] [Related]  

  • 30. Ovarian ablation as adjuvant therapy for early-stage breast cancer.
    Pritchard KI
    Cancer Treat Res; 1998; 94():158-80. PubMed ID: 9587687
    [No Abstract]   [Full Text] [Related]  

  • 31. Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data.
    Antman KH
    J Clin Oncol; 1999 Nov; 17(11 Suppl):30-4. PubMed ID: 10630259
    [No Abstract]   [Full Text] [Related]  

  • 32. Ethical and regulatory challenges in a randomized control trial of adjuvant treatment for breast cancer in Vietnam.
    Love RR; Fost NC
    J Investig Med; 1997 Oct; 45(8):423-31. PubMed ID: 9394094
    [No Abstract]   [Full Text] [Related]  

  • 33. [40 years of progress in chemotherapy].
    Cvitkovic-Bertheault F
    Pathol Biol (Paris); 2000 Nov; 48(9):812-8. PubMed ID: 11141916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized trials of high dose chemotherapy for breast cancer.
    Antman KH
    Biochim Biophys Acta; 2001 Mar; 1471(3):M89-98. PubMed ID: 11250065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rethinking research on psychosocial interventions in biopsychosocial oncology: an essay written in honor of the scholarly contributions of Bernard H. Fox.
    Temoshok LR
    Psychooncology; 2004 Jul; 13(7):460-7. PubMed ID: 15227715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whose 'wish bias'?
    Velasco-Garrido M; Busse R
    Ann Oncol; 2003 Jul; 14(7):1154-5; author reply 1154-5. PubMed ID: 12853362
    [No Abstract]   [Full Text] [Related]  

  • 37. Prospective: breast cancer adjuvant therapy after two decades. Clinical progress but a "partial circle" in investigation.
    Chlebowski RT
    Am J Clin Oncol; 1993 Dec; 16(6):532-5. PubMed ID: 8256773
    [No Abstract]   [Full Text] [Related]  

  • 38. The European experience.
    Höffken K
    J Clin Oncol; 2001 Sep; 19(18 Suppl):112S-117S. PubMed ID: 11560985
    [No Abstract]   [Full Text] [Related]  

  • 39. [The differences of standard therapy for breast cancer between Europe/America and Japan--chemotherapy, operation,and radiotherapy].
    Kitagawa D; Saji S
    Gan To Kagaku Ryoho; 2007 May; 34(5):690-3. PubMed ID: 17496438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring the intervention in effectiveness research.
    Sidani S
    West J Nurs Res; 1998 Oct; 20(5):621-35. PubMed ID: 9775742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.